In 17 of 22 cases (5.1%) without a conclusive histological diagnosis NGS resulted in a molecular tumor diagnosis (77.3%): 3 were diagnosed with oligodendroglioma (13.6%), 2 with astrocytoma (9.1%), 11 with glioblastoma (50.0%) and 1 with a BRAF-mutated tumor (4.5%). This evidence concerns the gene BRAF and neoplasm.